Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd. (also known as Biokin Pharmaceutical) is an innovative biomedical enterprise dedicated to addressing unmet clinical needs through synchronized R&D, production, and marketing. With full-series drug development capabilities spanning small-molecule chemicals, biologics, and ADC drugs, the company leverages integrated advantages from intermediates to APIs and formulations, covering the entire drug lifecycle. It operates R&D centers in China and the U.S. (SystImmune in Seattle) and four production bases (Guorui, Baili, Hiatt/Jingxi, and Baili-Bio) specializing in injectables, oral formulations, lyophilized products, and innovative biologics. Recognized as a national high-tech enterprise and multi-award winner for innovation (e.g., "Top 20 Innovative Pharmaceutical Enterprises in China"), Baili Pharmaceutical upholds a mission to deliver breakthrough therapies for global cancer patients, supported by a GMP-compliant quality system and a culture rooted in excellence, integrity, and global ambition.
CAS NO. 36791-04-5
CAS NO. 116539-59-4
CAS NO. 2377576-35-5
CAS NO. 33069-62-4
CAS NO. 231277-92-2
CAS NO. 439081-18-2
* If you have more purchasing needs, please seek help via email: net.fei@163.com